Advertisement

Related Videos

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Opening Session Panel Discussion

Issues in Oncology

The ASCO Post Staff

Leonard B. Saltz, MD, on Interventional Pharmacoeconomics: A Pathway to Better Cancer Care

Leonard B. Saltz, MD, of Memorial Sloan Kettering Cancer Center, discusses interventional pharmacoeconomics as an important tool that can offer patients with cancer more efficacious and cost-effective care. Pharmacoeconomics may help reduce the high costs of cancer therapy, with evidence-based reductions in doses that maintain effective treatment.

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Deborah Collyar: What's In It for Patients?

Advertisement

Advertisement




Apr
24
Today In Oncology
Polygenic Risk Score for Prostate Cancer Screening
Is This the End of Cancer Research as We Know It?
Benefits of Walnut Consumption Curbing Inflammation Colorectal Cancer Risk
Addition of Daratumumab to Treatment Regimen in Transplant-Ineligible Newly Diagnosed Multiple Myeloma
Response to Immune Checkpoint Inhibitors Not Affected by Age
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo